Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05519124 · ClinicalTrials.gov registry record · NA
BTL-785F Device for Non-invasive Reduction of Wrinkles
A NA study, sponsored by BTL Industries.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05519124 is a NA study that has completed, run by BTL Industries. The registered enrollment target is 20 participants.
The verdict
NCT05519124, a NA study, has completed, sponsored by BTL Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will evaluate the clinical safety and the performance of the BTL-785F system equipped with the BTL-785-7 applicator for non-invasive treatment of facial wrinkles. The study is a multicenter single-arm, open-label, interventional study.
Interventions
- DEVICE BTL-785-7
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-11-03 |
| Est. Completion | 2022-06-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05519124
The ClinicalTrials.gov registry entry for NCT05519124 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BTL Industries, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BTL-785-7 is the first listed.
NCT05519124 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05519124 about?
NCT05519124 is a clinical study titled "BTL-785F Device for Non-invasive Reduction of Wrinkles". This study will evaluate the clinical safety and the performance of the BTL-785F system equipped with the BTL-785-7 applicator for non-invasive treatment of facial wrinkles. The study is a multicenter single-arm, open-label, interventional study.
What is the current status of trial NCT05519124?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-11-03. Estimated completion is 2022-06-22.
What interventions are being tested in trial NCT05519124?
The interventions under investigation include: BTL-785-7 (DEVICE).
Who is sponsoring clinical trial NCT05519124?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.